Clinical Trial Information A Randomized, Controlled, Phase 1-2 Open Label Study of ST266 IV Administration to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants with Necrotizing Enterocolitis Protocol Number: 17226 Status: Open Age Group: Children Treatment Type: Treatment Phase: I/II NCT ID: NCT06315738 Scope Information Scope: National Disease Site(s): Other
